Risultati della ricerca - Christopher P. Cannon

Raffina i risultati
  1. 1
    Aspirin Resistance: Current Status and Role of Tailored Therapy

    Aspirin Resistance: Current Status and Role of Tailored Therapy di Jonathan Grinstein, Christopher P. Cannon

    Pubblicazione 2012
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  2. 2
    Acute Coronary Syndromes: Diagnosis and Management, Part II

    Acute Coronary Syndromes: Diagnosis and Management, Part II di Amit Kumar, Christopher P. Cannon

    Pubblicazione 2009
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Acute Coronary Syndromes: Diagnosis and Management, Part I

    Acute Coronary Syndromes: Diagnosis and Management, Part I di Amit Kumar, Christopher P. Cannon

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future

    PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future di Yuichi J. Shimada, Christopher P. Cannon

    Pubblicazione 2015
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

    Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation di Christopher P. Cannon, Gregory Y.H. Lip, Jonas Oldgren

    Pubblicazione 2018
    Testo
    Carta
    Aggiungi alla lista
    Salvato in:
  6. 6
    The Evolving Future of PCSK9 Inhibitors

    The Evolving Future of PCSK9 Inhibitors di Robert S. Rosenson, Robert A. Hegele, Sergio Fazio, Christopher P. Cannon

    Pubblicazione 2018
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  7. 7
    What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?

    What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes? di Sripal Bangalore, Jie Qin, Sarah Sloan, Sabina A. Murphy, Christopher P. Cannon

    Pubblicazione 2010
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Interaction Between Cigarette Smoking and Clinical Benefit of Clopidogrel

    Interaction Between Cigarette Smoking and Clinical Benefit of Clopidogrel di Nihar R. Desai, Jessica L. Mega, Songtao Jiang, Christopher P. Cannon, Marc S. Sabatine

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Identification of Genetic Variants Associated With Response to Statin Therapy

    Identification of Genetic Variants Associated With Response to Statin Therapy di Jessica L. Mega, David A. Morrow, Alison Brown, Christopher P. Cannon, Marc S. Sabatine

    Pubblicazione 2009
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Critical Pathways

    Critical Pathways di Nathan R. Every, Judith S. Hochman, Richard A. Becker, Steve Kopecky, Christopher P. Cannon

    Pubblicazione 2000
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial

    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial di Petr Jarolı́m, William B. White, Christopher P. Cannon, Qi Gao, David A. Morrow

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)

    Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registr... di James Underberg, Christopher P. Cannon, Dominique Larrey, Lukas Makris, Dirk Blom, Helen Phillips

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy

    Meta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy di Christopher P. Cannon, Benjamin A. Steinberg, Sabina A. Murphy, Jessica L. Mega, Eugene Braunwald

    Pubblicazione 2006
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  14. 14
    Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction

    Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction di Hal V. Barron, Christopher P. Cannon, Sabina A. Murphy, Eugene Braunwald, C. Michael Gibson

    Pubblicazione 2000
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis

    Common Pathophysiology in Cancer, Atrial Fibrillation, Atherosclerosis, and Thrombosis di Orly Leiva, Duaa AbdelHameid, Jean M. Connors, Christopher P. Cannon, Deepak L. Bhatt

    Pubblicazione 2021
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  16. 16
    Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

    Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial di Michael Miller, Christopher P. Cannon, Sabina A. Murphy, Jie Qin, Kausik K. Ray, Eugene Braunwald

    Pubblicazione 2008
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease

    Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease di George Thanassoulis, Ken Williams, Kathleen K. Altobelli, Michael Pencina, Christopher P. Cannon, Allan D. Sniderman

    Pubblicazione 2016
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Benefit of Intensive Statin Therapy in Women

    Benefit of Intensive Statin Therapy in Women di Quynh A. Truong, Sabina A. Murphy, Carolyn H. McCabe, Annemarie Armani, Christopher P. Cannon

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes

    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndro... di Kausik K. Ray, Christopher P. Cannon, Richard Cairns, David A. Morrow, Paul M. Ridker, Eugene Braunwald

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy

    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy di Stephen D. Wiviott, Christopher P. Cannon, David A. Morrow, Kausik K. Ray, Marc A. Pfeffer, Eugene Braunwald

    Pubblicazione 2005
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: